1. Home
  2. WWW vs KARD Comparison

WWW vs KARD Comparison

Compare WWW & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

N/A

Current Price

$22.71

Market Cap

1.6B

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$14.30

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WWW
KARD
Founded
1883
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2003
2026

Fundamental Metrics

Financial Performance
Metric
WWW
KARD
Price
$22.71
$14.30
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$24.30
★ $41.13
AVG Volume (30 Days)
★ 875.9K
513.7K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
★ 1.82%
N/A
EPS Growth
★ 96.55
N/A
EPS
★ 0.61
N/A
Revenue
★ $1,874,300,000.00
N/A
Revenue This Year
$6.78
N/A
Revenue Next Year
$5.83
$50.00
P/E Ratio
$35.87
★ N/A
Revenue Growth
★ 6.80
N/A
52 Week Low
$14.00
$12.23
52 Week High
$23.84
$27.00

Technical Indicators

Market Signals
Indicator
WWW
KARD
Relative Strength Index (RSI) 62.88 48.64
Support Level $15.71 $13.75
Resistance Level $23.84 $15.93
Average True Range (ATR) 1.09 1.21
MACD 0.12 0.26
Stochastic Oscillator 74.50 47.78

Price Performance

Historical Comparison
WWW
KARD

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: